CoChat
Sign Up
Cited by 160Blood Pressure and Hypertension StudiesTelemedicine and Telehealth ImplementationMedication Adherence and Compliance

The DOI matches its Crossref record; 27 of the 32 references it cites were found in a registry or an index.

Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial

Open access
Margolis, Karen L., Asche, Stephen E., Dehmer, Steven P., Bergdall, Anna R., Green, Beverly B., Sperl-Hillen, JoAnn M., Nyboer, Rachel A., Pawloski, Pamala A., Maciosek, Michael V., Trower, Nicole K., O’Connor, Patrick J.·2018·JAMA Network Open
DOI 10.1001/jamanetworkopen.2018.1617PMC PMC6324502
Open this paper in CoChat — free accountOpen PDF

Abstract

Importance: Hypertension is a leading cause of cardiovascular disease. The results were previously reported of a trial of home blood pressure (BP) telemonitoring and pharmacist management intervention in which the interventions stopped after 12 months. There were significantly greater reductions in systolic BP (SBP) in the intervention group than in the usual care group at 6, 12, and 18 months (-10.7, -9.7, and -6.6 mm Hg, respectively). Objectives: To examine the durability of the intervention effect on BP through 54 months of follow-up and to compare BP measurements performed in the research clinic and in routine clinical care. Design, Setting, and Participants: Follow-up of a cluster randomized clinical trial among 16 primary care clinics and 450 patients with uncontrolled hypertension in a large health system from March 2009 to November 2015. Interventions: A home BP telemonitoring intervention with pharmacist management or usual care. Main Outcomes and Measures: Change from baseline to 54 months in SBP and diastolic BP (DBP) measured as the mean of 3 measurements obtained at each research clinic visit. Results: Among 450 patients, 228 (mean [SD] age, 62.0 [11.7] years; 54.8% male) were randomized to the telemonitoring intervention and 222 (mean [SD] age, 60.2 [12.2] years; 55.9% male) to usual care. Research clinic BP measurements were obtained from 326 of 450 (72.4%) study patients at the 54-month follow-up visit, including 162 (mean [SD] age, 62.0 [11.1] years; 54.9% male) randomized to the telemonitoring intervention and 164 (mean [SD] age, 60.0 [11.2] years; 57.3% male) to usual care. Routine clinical care BP measurements were obtained from 439 of 450 (97.6%) study patients at 6248 visits during the follow-up period. Based on research clinic measurements, baseline mean SBP was 148 mm Hg in both groups. In the intervention group, mean SBP at 6-, 12-, 18-, and 54-month follow-up was 126.7, 125.7, 126.9, and 130.6 mm Hg, respectively. In the usual care group, mean SBP at 6-, 12-, 18-, and 54-month follow-up was 136.9, 134.8, 133.0, and 132.6 mm Hg, respectively. The differential reduction by study group in SBP from baseline to 54 months was -2.5 mm Hg (95% CI, -6.3 to 1.2 mm Hg; P = .18). The DBP followed a similar pattern, with a differential reduction by study group from baseline to 54 months of -1.0 mm Hg (95% CI, -3.2 to 1.2 mm Hg; P = .37). The SBP and DBP results from routine clinical measurements suggested significantly lower BP in the intervention group for up to 24 months. Conclusions and Relevance: This intensive intervention had sustained effects for up to 24 months (12 months after the intervention ended). Long-term maintenance of BP control is likely to require continued monitoring and resumption of the intervention if BP increases. Trial Registration: ClinicalTrials.gov Identifier: NCT00781365.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamanetworkopen.2018.1617

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 32 references

5 of the 32 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Items 101–160 of 160

Related

See all

Metadata

Authors
Margolis, K. L., Asche, S. E., Dehmer, S. P., Bergdall, A. R., Green, B. B., Sperl-Hillen, J. M., Nyboer, R. A., Pawloski, P. A., Maciosek, M. V., Trower, N. K., & O’Connor, P. J.
Affiliations
  • HealthPartners (US)
  • Kaiser Permanente Washington Health Research Institute (US)
  • HealthPartners Institute for Education and Research, Minneapolis, Minnesota
Corresponding author
Margolis, Karen L.
ORCID
Venue
JAMA Network Open
Publisher
American Medical Association (AMA)
Published
2018-09-07
Volume
1
Issue
5
Pages
e181617
ISSN
2574-3805 (ISSN-L)
DOI
10.1001/jamanetworkopen.2018.1617
PMC
PMC6324502
OpenAlex
W2889669989
Cited by
160
References
32
Citations by year
2026: 18 · 2025: 21 · 2024: 15 · 2023: 22 · 2022: 25 · 2021: 25 · 2020: 23 · 2019: 9 · 2018: 2
FWCI
11.14
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • JAMA Network Open (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Kaiser Permanente
  • Patient-Centered Outcomes Research Institute
  • Kaiser Permanente Washington Health Research Institute
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01HL090965)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK092924)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Keywords
uncontrolled hypertension, home blood pressure telemonitoring, pharmacist management, blood pressure control, systolic blood pressure, diastolic blood pressure, intervention durability, primary care, cardiovascular risk reduction, usual care comparison, long-term follow-up, medication adherence, lifestyle counseling, drug costs
MeSH terms
Aged, Antihypertensive Agents, Blood Pressure, Community Pharmacy Services, Drug Therapy, Female, Follow-Up Studies, Humans, Hypertension, Male, Middle Aged, Minnesota, Professional-Patient Relations, Telemetry, Blood Pressure Monitoring, Ambulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review